About Lily MedTech
Lily MedTech is a company based in Tokyo (Japan) founded in 2016.. Lily MedTech has raised $3.31 million across 2 funding rounds from investors including Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital. Lily MedTech operates in a competitive market with competitors including OncoStem, PreludeDx, Miltel, POC Medical Systems and Inbiomotion, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.31 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Beyond Next Ventures
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Lily MedTech
Lily MedTech has successfully raised a total of $3.31M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(28 Mar 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Series A - Lily MedTech | Valuation |
investors |
|
| Mar, 2018 | Amount | Series A - Lily MedTech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lily MedTech
Lily MedTech has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in AI, energy, and various sectors.
|
Founded Year | Domain | Location | |
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Founded Year | Domain | Location | |
|
Science and technology research funding and event organization in Japan.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lily MedTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lily MedTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lily Medtech Comparisons
Competitors of Lily MedTech
Lily MedTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OncoStem, PreludeDx, Miltel, POC Medical Systems and Inbiomotion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| domain | founded_year | HQ Location |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| domain | founded_year | HQ Location |
Telomere tests for aging detection and cellular senescence are provided.
|
|
| domain | founded_year | HQ Location |
Develops rapid tools for breast cancer detection and disease screening worldwide.
|
|
| domain | founded_year | HQ Location |
Biomarkers for predicting bone metastasis in cancer patients are developed.
|
|
| domain | founded_year | HQ Location |
uPAR-based PET ligands for breast cancer imaging are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Lily MedTech
When was Lily MedTech founded?
Lily MedTech was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Lily MedTech located?
Lily MedTech is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Who is the current CEO of Lily MedTech?
Shiho Azuma is the current CEO of Lily MedTech.
Is Lily MedTech a funded company?
Lily MedTech is a funded company, having raised a total of $3.31M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.31M, raised on Mar 28, 2018.
What does Lily MedTech do?
Lily MedTech was established in 2016 as a venture from the University of Tokyo. Diagnostic imaging equipment utilizing ultrasound technology for breast cancer detection is being developed by the company within the medtech sector. Operations are conducted from Tokyo, Japan, where the focus remains on advancing non-invasive diagnostic solutions. Leadership is provided by CEO Shiho Azuma, with emphasis placed on research and equipment innovation.
Who are the top competitors of Lily MedTech?
Who are Lily MedTech's investors?
Lily MedTech has 4 investors. Key investors include Beyond Next Ventures, Fuyo General Lease, Mitsubishi UFJ Capital, and Japan Science and Technology Agency.